Complex Clinical Trials (CCTs) have the potential to accelerate drug development and enable patients to get timely access to transformative ;The main objective of this workshop is to develop shared solutions by:

• What is CCT – simplifying and standardising definition of CCT
• Why CCTs – how CCT can accelerate drug development
• Discussing CCTs challenges and potential solutions with stakeholders experts (regulators, HTA bodies/payers, academia, patients’ organisations and industry)  through shared experience with CCTs
• Identifying emerging best practices to facilitate the use and acceptance of CCTs
• Defining an action plan to gain acceptance of CCTs supporting regulatory decision-making
• Defining educational needs on CCTs across all stakeholders
• Discussing global implications of CCTs; Identifying opportunities and unique differentiation factors for conducting CCT in Europe ( CTIS)
• Discussing interaction/synergies with existing initiatives, , IMI EU-PEARL,

The hands-on workshop format features use of case examples and interactive sessions to facilitate co-creation of solutions and active contribution by participants.

Organised by EFPIA